Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mismetti

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 11, 2010
Is there really a relationship between the plasma concentration of the active metabolite of clopidogrel and the results of platelet function tests?X Delavenne, N Mallouk, M Piot, et al.
Pharmacoepidemiology and Drug Safety|October 26, 2006
Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France, A Leizorovicz, A Cohen, et al.
Fundamental & Clinical Pharmacology|January 1, 1990
Good clinical practices in phase I studiesH Decousus, B Perpoint, P Mismetti, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administrationP Zufferey, S Laporte, S Molliex, et al.
European Journal of Internal Medicine|May 23, 2016
Comparison of blood coagulation factors between patients with gastrointestinal or intracranial bleeding under vitamin K antagonistsF Moustafa, J Saint-Denis, S Laporte, et al.
The British Journal of Surgery|July 10, 2001
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgeryP Mismetti, S Laporte, J Y Darmon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 16, 2018
Individualized PK-based prophylaxis in severe haemophiliaY Dargaud, X Delavenne, D P Hart, et al.
Therapie|March 10, 1999
[Evaluation of the risk of venous thromboembolism in the medical patients]P Mismetti, D Juillard-Delsart, B Tardy, et al.
Statistics in Medicine|May 15, 1995
Influence of confounding factors on designs for dose-effect relationship estimatesP Girard, S Laporte-Simitsidis, P Mismetti, et al.
Presse Medicale (Paris, France : 1983)|October 29, 1994
[Hypereosinophilia and cutaneous lesions caused by low-molecular-weight heparin]A Dacosta, P Mismetti, A Buchmuller, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Journal of Thrombosis and Haemostasis : JTH|August 11, 2010
Is there really a relationship between the plasma concentration of the active metabolite of clopidogrel and the results of platelet function tests?X Delavenne, N Mallouk, M Piot, et al.
Pharmacoepidemiology and Drug Safety|October 26, 2006
Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France, A Leizorovicz, A Cohen, et al.
Fundamental & Clinical Pharmacology|January 1, 1990
Good clinical practices in phase I studiesH Decousus, B Perpoint, P Mismetti, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administrationP Zufferey, S Laporte, S Molliex, et al.
European Journal of Internal Medicine|May 23, 2016
Comparison of blood coagulation factors between patients with gastrointestinal or intracranial bleeding under vitamin K antagonistsF Moustafa, J Saint-Denis, S Laporte, et al.
The British Journal of Surgery|July 10, 2001
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgeryP Mismetti, S Laporte, J Y Darmon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 16, 2018
Individualized PK-based prophylaxis in severe haemophiliaY Dargaud, X Delavenne, D P Hart, et al.
Therapie|March 10, 1999
[Evaluation of the risk of venous thromboembolism in the medical patients]P Mismetti, D Juillard-Delsart, B Tardy, et al.
Statistics in Medicine|May 15, 1995
Influence of confounding factors on designs for dose-effect relationship estimatesP Girard, S Laporte-Simitsidis, P Mismetti, et al.
Presse Medicale (Paris, France : 1983)|October 29, 1994
[Hypereosinophilia and cutaneous lesions caused by low-molecular-weight heparin]A Dacosta, P Mismetti, A Buchmuller, et al.
Pageof 11